Hansa Biopharma AB (publ) (STO:HNSA)
Sweden flag Sweden · Delayed Price · Currency is SEK
26.20
+0.32 (1.24%)
Jul 23, 2025, 5:29 PM CET

Hansa Biopharma AB Statistics

Total Valuation

STO:HNSA has a market cap or net worth of SEK 2.22 billion. The enterprise value is 2.77 billion.

Market Cap2.22B
Enterprise Value 2.77B

Important Dates

The last earnings date was Thursday, July 17, 2025.

Earnings Date Jul 17, 2025
Ex-Dividend Date n/a

Share Statistics

STO:HNSA has 84.76 million shares outstanding. The number of shares has increased by 23.88% in one year.

Current Share Class 84.76M
Shares Outstanding 84.76M
Shares Change (YoY) +23.88%
Shares Change (QoQ) +4.41%
Owned by Insiders (%) 6.63%
Owned by Institutions (%) 10.18%
Float 45.93M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 11.30
PB Ratio -5.04
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -4.65
EV / Sales 14.11
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.37

Current Ratio 1.37
Quick Ratio 1.36
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -6.22

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -35.83%
Return on Invested Capital (ROIC) -54.78%
Return on Capital Employed (ROCE) -128.86%
Revenue Per Employee 1.40M
Profits Per Employee -4.26M
Employee Count135
Asset Turnover 0.21
Inventory Turnover 25.16

Taxes

In the past 12 months, STO:HNSA has paid 4.14 million in taxes.

Income Tax 4.14M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -34.38% in the last 52 weeks. The beta is 1.54, so STO:HNSA's price volatility has been higher than the market average.

Beta (5Y) 1.54
52-Week Price Change -34.38%
50-Day Moving Average 25.21
200-Day Moving Average 28.89
Relative Strength Index (RSI) 50.18
Average Volume (20 Days) 353,227

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, STO:HNSA had revenue of SEK 196.47 million and -596.68 million in losses. Loss per share was -8.72.

Revenue196.47M
Gross Profit 132.81M
Operating Income -535.04M
Pretax Income -592.54M
Net Income -596.68M
EBITDA -532.63M
EBIT -535.04M
Loss Per Share -8.72
Full Income Statement

Balance Sheet

The company has 354.42 million in cash and 906.21 million in debt, giving a net cash position of -551.79 million or -6.51 per share.

Cash & Cash Equivalents 354.42M
Total Debt 906.21M
Net Cash -551.79M
Net Cash Per Share -6.51
Equity (Book Value) -441.06M
Book Value Per Share -5.20
Working Capital 156.84M
Full Balance Sheet

Cash Flow

Operating Cash Flow -560.18M
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin 67.60%
Operating Margin -272.33%
Pretax Margin -301.59%
Profit Margin n/a
EBITDA Margin -271.10%
EBIT Margin -272.33%
FCF Margin n/a

Dividends & Yields

STO:HNSA does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -23.88%
Shareholder Yield n/a
Earnings Yield -26.87%
FCF Yield n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 4